Table 3.
Comparison of Changes in Biochemical Parameters Over 12 Months in the NONE, PILL, and PATCH Groups (Within- and Between-Group Comparisons)
| Change Over 12 Months | NONE (n = 26) | P Valuea | PILL (n = 21) | P Valuea | PATCH (n = 26) | P Valuea | ANOVA P Valueb | P Values | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PILL vs NONE | PATCH vs NONE | PATCH vs PILL | ||||||||
| Δ 25(OH)D (ng/mL) | 1.55 ± 1.60 | 0.344 | 2.78 ± 2.21 | 0.224 | −0.17 ± 1.35 | 0.904 | 0.482 | 0.871 | 0.743 | 0.458 |
| Δ Calcium (mg/dL) | 0.02 ± 0.08 | 0.842 | 0.06 ± 0.12 | 0.624 | 0.05 ± 0.09 | 0.611 | 0.945 | 0.944 | 0.970 | 0.995 |
| Δ PTH (pg/mL) | 0.40 ± 2.42 | 0.870 | −0.27 ± 3.09 | 0.925 | 1.60 ± 1.94 | 0.418 | 0.857 | 0.979 | 0.931 | 0.849 |
| Δ P1NP (ng/mL) | −14.6 (–34.1 to 9.6) | 0.049 | −26.0 (–64.8 to –18.5) | 0.0003 | −11.5 (–38.8 to 4.6) | 0.031 | 0.033 | 0.070 | 0.978 | 0.053 |
| Δ NTX (nM BCE/L) | −0.9 (–5.0 to 1.6) | 0.035 | −1.4 (–4.1 to 1.4) | 0.146 | −2.0 (–5.0 to 0.7) | 0.128 | 0.907 | 0.997 | 0.952 | 0.907 |
| Δ IGF-1 (ng/mL) | −8.8 ± 15.8 | 0.584 | −65.2 ± 21.2 | 0.006 | −10.2 ± 13.2 | 0.448 | 0.037 | 0.052 | 0.998 | 0.066 |
| Δ IGF-1 z score | 0.11 ± 0.13 | 0.414 | −0.56 ± 0.22 | 0.018 | 0.05 ± 0.16 | 0.780 | 0.014 | 0.018 | 0.959 | 0.039 |
| Δ IGFBP-3 (ng/mL) | −236.6 ± 93.8 | 0.024 | 252.4 ± 153.7 | 0.129 | −409.5 ± 163.7 | 0.028 | 0.006 | 0.040 | 0.633 | 0.006 |
| Δ IGF-1/IGFBP-3 | −0.0006 ± 0.0029 | 0.831 | −0.0186 ± 0.0030 | <0.0001 | 0.0015 ± 0.0033 | 0.6464 | 0.001 | 0.003 | 0.887 | 0.002 |
| Δ Testosterone (ng/dL) | −1.12 ± 1.79 | 0.537 | −0.68 ± 4.16 | 0.866 | −1.84 ± 2.21 | 0.414 | 0.955 | 0.993 | 0.980 | 0.952 |
| Δ Estradiol (pg/mL) | −1.5 (–13.9 to 47.8) | 0.079 | −20.0 (–89.0 to 0.0) | 0.047 | 45.0 (11.5 to 73.8) | 0.0009 | <0.0001 | 0.076 | 0.014 | <0.0001 |
| Δ SHBG (nmol/L) | −5.3 (–14.0 to 12) | 0.359 | 152.4 (99.1 to 232.3) | <0.0001 | 4.6 (–10.5 to 16.1) | 0.814 | <0.0001 | <0.0001 | 0.819 | <0.0001 |
| Δ FAI | −0.1 (–0.8 to 0.7) | 0.613 | −1.1 (–2.0 to –0.6) | 0.0001 | −0.1 (–1.0 to 0.7) | 0.313 | 0.003 | 0.004 | 0.990 | 0.015 |
| Δ Sclerostin (pg/mL) | 12.4 ± 16.7 | 0.467 | −45.6 ± 13.8 | 0.005 | −58.2 ± 20.0 | 0.012 | 0.010 | 0.045 | 0.014 | 0.863 |
| Δ Pref–1 (pg/mL) | 2.0 (–16.4 to 41.5) | 0.691 | −8.3 (–36.7 to –1.2) | 0.055 | −33.5 (–64.6 to 5.1) | 0.014 | 0.838 | 0.943 | 0.825 | 0.970 |
| Δ BDNF (ng/mL) | 0.31 (–26.54 to 5.66) | 0.809 | 1.03 (–7.97 to 6.13) | 0.801 | −6.36 (–11.19 to 0.97) | 0.044 | 0.131 | 0.998 | 0.113 | 0.336 |
Bold type indicates statistically significant P value of <0.05.
Mean ± SEM; median (first quartile to third quartile).
P value for within-group comparison (paired t test or signed rank test).
ANOVA P value for between-group comparisons.